Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Trading Update

23 Jul 2015 07:00

RNS Number : 8211T
Biome Technologies PLC
23 July 2015
 



 

23 July 2015

Biome Technologies plc

 

 ("Biome", "the Company" or "the Group")

 

Trading Update

 

 

Biome Technologies plc, a leading bioplastics and radio frequency technology business, today publishes its trading update for the six-month period ended 30 June 2015. The interim results are expected to be announced on 2 September 2015.

 

Trading Update

Total Group Revenues for the first half were £2.1m (H1 2014 £2.3m), including revenues for the second quarter of 2015 of £0.9m (Q1 2015: £1.1m). The turnover for the second quarter maintains the significant progress made in the first quarter of 2015 albeit partly constrained by later phasing of shipments from the RF Technologies Division.

 

The Group's cash position at 30 June 2015 was £1.8m (31 March 2015: £2.3m), reflecting both an increase in working capital ahead of expected shipments in Q3, new product development costs and trading performance.

 

 

Bioplastics Division

Revenues generated by the Bioplastics Division in the first half of 2015 totalled £1.0m (H1 2014 £1.1m).

 

Order levels of the division's commercialised products have recovered substantially in the first half of this year, driven by an improvement in the US market which has seen demand return to levels broadly similar to those seen in the first half of 2014.

 

Additionally, the second half of this year should be favourably impacted by a new product line we have developed reaching its commercialisation phase; initial order rates are already encouraging.

 

Three grant supported research collaborations focused on bio-based materials, highlighted in previous statements, commenced in the first half.

 

Stanelco RF Technologies Division

Revenues for this division in the first half of 2015 were £1.0m (2014: £1.2m). A robust and significant order book for the remainder of the year should see the turnover weighting for the second half substantially above that of the first half of 2015.

 

The recently announced signing of a £1.1m contract to supply optic fibre furnaces in the second half of the year will add considerably to the division's existing pipeline. Additional enquiries indicate that the optic fibre furnace market is more buoyant than it has been for some time, with customers seeking upgrades as well as additional capacity. The contract with a customer from a regulated industry is progressing on time and to plan with the delivery of the first system anticipated in the second half.

 

Group Outlook

Group revenues at the mid-year point are in line with the Board's expectations with a reduced operating loss during the period relative to those expectations. The Board is confident that momentum in revenue growth should accelerate in the second half of the year.

 

-Ends-

 

 

For further information please contact:

 

Biome Technologies plc

Paul Mines, Chief Executive Officer

Declan Brown, Group Finance Director

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

Allenby Capital

David Hart/Alex Brearley (Nominated Adviser)

Chris Crawford/Kelly Gardiner (Broker)

www.allenbycapital.com

Tel: +44 (0) 20 3328 5656

FTI Consulting

Oliver Winters

www.fticonsulting.com

Tel: +44 (0) 20 3727 1535

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPKBDKABKDKOB
Date   Source Headline
18th Apr 202310:49 amRNSCompletion of CLN Fundraising
17th Apr 202311:30 amRNSResult of General Meeting
31st Mar 202311:14 amRNSProposed issue of Convertible Loan Notes
25th Jan 20237:00 amRNSTrading Update
16th Nov 20227:00 amRNSBiome receives £282k grant
10th Nov 202211:05 amRNSSecond Price Monitoring Extn
10th Nov 202211:00 amRNSPrice Monitoring Extension
10th Nov 20227:00 amRNSTrading Update
18th Oct 20229:28 amRNSHolding(s) in Company
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
22nd Sep 20222:05 pmRNSSecond Price Monitoring Extn
22nd Sep 20222:00 pmRNSPrice Monitoring Extension
22nd Sep 20229:05 amRNSSecond Price Monitoring Extn
22nd Sep 20229:00 amRNSPrice Monitoring Extension
22nd Sep 20227:00 amRNSInterim Results
5th Sep 20227:00 amRNSGrant funding from Innovate UK
2nd Aug 20228:59 amRNSTrading Update - Replacement
2nd Aug 20227:00 amRNSTrading Update
20th Apr 202212:01 pmRNSResult of Annual General Meeting
20th Apr 20227:00 amRNSTrading Update
30th Mar 20222:48 pmRNSDirector/PDMR Shareholding
30th Mar 20227:00 amRNSNotice of AGM and 2021 Annual Report
24th Mar 20227:00 amRNSFinal Results 2021
27th Jan 20227:00 amRNSTrading Update
4th Jan 202210:33 amRNSFurther substantial contract win for RF Division
16th Dec 20218:41 amRNSContract
17th Nov 20217:00 amRNSTrading Update
9th Nov 202111:12 amRNSHolding(s) in Company
25th Oct 20217:00 amRNSUpdate re biodegradable tree shelters
15th Sep 20217:00 amRNSInterim Results
30th Jul 20219:47 amRNSDirector/PDMR Shareholding
29th Jul 20217:00 amRNSTrading Update
1st Jul 20219:05 amRNSSecond Price Monitoring Extn
1st Jul 20219:00 amRNSPrice Monitoring Extension
1st Jul 20217:00 amRNSTrading Update
30th Jun 20215:00 pmRNSTotal Voting Rights
7th Jun 202110:50 amRNSHolding(s) in Company
2nd Jun 20217:00 amRNSIssue of Equity and TVR
28th May 20217:00 amRNSAward under 2017 Long Term Incentive Plan
30th Apr 20215:00 pmRNSTotal Voting Rights
27th Apr 20214:25 pmRNSHolding(s) in Company
21st Apr 202110:51 amRNSHolding(s) in Company
21st Apr 202110:19 amRNSResult of Annual General Meeting
21st Apr 20217:00 amRNSTrading Update
9th Apr 20211:40 pmRNSPDMR Shareholding and transaction in own shares
1st Apr 202110:04 amRNSIssue of equity and Transaction in own shares
29th Mar 20217:00 amRNSNotice of AGM and Annual Report
25th Mar 20217:01 amRNSFinal Results 2020
25th Mar 20217:00 amRNSAppointment of New Non-Executive Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.